Accenture plc (ACN) concluded trading on Thursday at a closing price of $300.91, with 10.69 million shares of worth about $3.22 billion changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -10.72% during that period and on March 20, 2025 the price saw a loss of about -7.26%. Currently the company’s common shares owned by public are about 625.03M shares, out of which, 623.82M shares are available for trading.
Stock saw a price change of -5.10% in past 5 days and over the past one month there was a price change of -22.89%. Year-to-date (YTD), ACN shares are showing a performance of -14.46% which decreased to -19.26% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $278.69 but also hit the highest price of $398.35 during that period. The average intraday trading volume for Accenture plc shares is 2.89 million. The stock is currently trading -11.19% below its 20-day simple moving average (SMA20), while that difference is down -16.31% for SMA50 and it goes to -12.41% lower than SMA200.
Accenture plc (NYSE: ACN) currently have 625.03M outstanding shares and institutions hold larger chunk of about 77.93% of that.
The stock has a current market capitalization of $188.21B and its 3Y-monthly beta is at 1.30. PE ratio of stock for trailing 12 months is 25.22, while it has posted earnings per share of $11.93 in the same period. Its PEG reads 3.12 and has Quick Ratio of 1.47 while making debt-to-equity ratio of 0.28. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ACN, volatility over the week remained 2.49% while standing at 2.45% over the month.
Stock’s fiscal year EPS is expected to rise by 6.44% while it is estimated to increase by 8.03% in next year. EPS is likely to shrink at an annualized rate of 8.08% for next 5-years, compared to annual growth of 9.21% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Robert W. Baird on March 17, 2025 offering an Outperform rating for the stock and assigned a target price of $390 to it. Coverage by Wolfe Research stated Accenture plc (ACN) stock as an Outperform in their note to investors on January 08, 2025, suggesting a price target of $425 for the stock. On December 06, 2024, Goldman Upgrade their recommendations, while on October 30, 2024, Exane BNP Paribas Downgrade their ratings for the stock with a price target of $375. Stock get a Buy rating from TD Cowen on September 30, 2024.
